Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Saletu

Showing results (41-50 of 63) with videos related to

Pageof 7
Sort By:
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 28, 2005
Double-blind, placebo-controlled pharmacodynamic studies with a nutraceutical and a pharmaceutical dose of ademetionine (SAMe) in elderly subjects, utilizing EEG mapping and psychometryO Arnold, B Saletu, P Anderer, et al.
Neuropsychobiology|June 1, 2000
Sleep laboratory studies in restless legs syndrome patients as compared with normals and acute effects of ropinirole. 1. Findings on objective and subjective sleep and awakening qualityB Saletu, G Gruber, M Saletu, et al.
Neuropsychobiology|June 1, 2000
Sleep laboratory studies in restless legs syndrome patients as compared with normals and acute effects of ropinirole. 2. Findings on periodic leg movements, arousals and respiratory variablesM Saletu, P Anderer, B Saletu, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|November 12, 1998
Psychophysiological diagnostics in alcohol dependency: Fourier analysis of pupillary oscillations and the receptor test for determination of cholinergic deficiencyJ Grünberger, L Linzmayer, H Walter, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|October 9, 2010
Comparative EEG mapping studies in Huntington's disease patients and controlsAnnamaria Painold, Peter Anderer, Anna K Holl, et al.
Sleep|December 20, 2002
Modafinil for the treatment of daytime sleepiness in Parkinson's disease: a double-blind, randomized, crossover, placebo-controlled polygraphic trialB Högl, M Saletu, E Brandauer, et al.
Human Psychopharmacology|January 9, 2008
Double-blind, placebo-controlled, multiple-ascending-dose study on the effects of ABIO-08/01, a novel anxiolytic drug, on perception and cognition, utilizing event-related potential mapping and low-resolution brain electromagnetic tomographyPeter Anderer, Bernd Saletu, Michael Wolzt, et al.
Journal of Neurology|December 17, 2010
EEG low-resolution brain electromagnetic tomography (LORETA) in Huntington's diseaseAnnamaria Painold, Peter Anderer, Anna K Holl, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 3, 2007
Cabergoline compared to levodopa in the treatment of patients with severe restless legs syndrome: results from a multi-center, randomized, active controlled trialClaudia Trenkwalder, Heike Benes, Ludger Grote, et al.
Neuropsychobiology|April 15, 2009
Double-blind, placebo-controlled, multiple-ascending-dose study on the pharmacodynamics of ABIO-08/01, a new CNS drug with potential anxiolytic activity. 2. EEG-tomography findings based on LORETA (low-resolution brain electromagnetic tomography)Bernd Saletu, Peter Anderer, Michael Wolzt, et al.
Pageof 7

Showing results (41-50 of 63) with videos related to

Sort By:
Pageof 7
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 28, 2005
Double-blind, placebo-controlled pharmacodynamic studies with a nutraceutical and a pharmaceutical dose of ademetionine (SAMe) in elderly subjects, utilizing EEG mapping and psychometryO Arnold, B Saletu, P Anderer, et al.
Neuropsychobiology|June 1, 2000
Sleep laboratory studies in restless legs syndrome patients as compared with normals and acute effects of ropinirole. 1. Findings on objective and subjective sleep and awakening qualityB Saletu, G Gruber, M Saletu, et al.
Neuropsychobiology|June 1, 2000
Sleep laboratory studies in restless legs syndrome patients as compared with normals and acute effects of ropinirole. 2. Findings on periodic leg movements, arousals and respiratory variablesM Saletu, P Anderer, B Saletu, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|November 12, 1998
Psychophysiological diagnostics in alcohol dependency: Fourier analysis of pupillary oscillations and the receptor test for determination of cholinergic deficiencyJ Grünberger, L Linzmayer, H Walter, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|October 9, 2010
Comparative EEG mapping studies in Huntington's disease patients and controlsAnnamaria Painold, Peter Anderer, Anna K Holl, et al.
Sleep|December 20, 2002
Modafinil for the treatment of daytime sleepiness in Parkinson's disease: a double-blind, randomized, crossover, placebo-controlled polygraphic trialB Högl, M Saletu, E Brandauer, et al.
Human Psychopharmacology|January 9, 2008
Double-blind, placebo-controlled, multiple-ascending-dose study on the effects of ABIO-08/01, a novel anxiolytic drug, on perception and cognition, utilizing event-related potential mapping and low-resolution brain electromagnetic tomographyPeter Anderer, Bernd Saletu, Michael Wolzt, et al.
Journal of Neurology|December 17, 2010
EEG low-resolution brain electromagnetic tomography (LORETA) in Huntington's diseaseAnnamaria Painold, Peter Anderer, Anna K Holl, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 3, 2007
Cabergoline compared to levodopa in the treatment of patients with severe restless legs syndrome: results from a multi-center, randomized, active controlled trialClaudia Trenkwalder, Heike Benes, Ludger Grote, et al.
Neuropsychobiology|April 15, 2009
Double-blind, placebo-controlled, multiple-ascending-dose study on the pharmacodynamics of ABIO-08/01, a new CNS drug with potential anxiolytic activity. 2. EEG-tomography findings based on LORETA (low-resolution brain electromagnetic tomography)Bernd Saletu, Peter Anderer, Michael Wolzt, et al.
Pageof 7